← SynDRA
IC87114
SynDRA canonical compound SYN1948528 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PIK3C2B | PIK3CD | PIK3CG |
|---|
| Mechanism of action | pi3k inhibitor |
|---|
| Indication | acute myeloid leukemia (aml) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
Mechanisms of action (all sources)
- PI3K inhibitor
- PIK3CD INHIBITOR
Cross-references
Synonyms
- IC 87114
- 2-((6-amino-9H-purin-9-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one
- UNII-9HC746B1KF
- 2-[(6-AMINO-9H-PURIN-9-YL)METHYL]-5-METHYL-3-(2-METHYLPHENYL)-4(3H)-QUINAZOLINONE
- 9HC746B1KF
- CHEMBL1213082
- CHEBI:90686
- D-030
- 2-[(6-aminopurin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one
- 2-[(6-Amino-9h-Purin-9-Yl)methyl]-5-Methyl-3-(2-Methylphenyl)quinazolin-4(3h)-One
- BiomolKI2_000002
- GNWHRHGTIBRNSM-UHFFFAOYSA-N
- PubChem22453
- MLS006011148
- SCHEMBL360745
- GTPL9376
- EX-A326
Look up IC87114 in the interactive SynDRA portal →